Biogen Inc.
BIIBNASDAQHealthcare● Active
$192.62
$-2.72(-1.39%)
Market Cap$28.4B
P/E Ratio—
52W High$205.97
52W Low$121.05
Biogen Inc.（BIIB）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BIIB · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $3.82B | $2.38B | $1.05B | $4.89B | $3.80B |
| Net Receivables | $1.87B | $1.87B | $2.10B | $2.14B | $1.96B |
| Inventory | $2.17B | $2.46B | $2.53B | $1.34B | $1.35B |
| Total Current Assets | $8.97B | $7.46B | $6.86B | $9.79B | $7.86B |
| PP&E Net | $3.32B | $3.54B | $3.73B | $3.70B | $3.79B |
| Goodwill | $6.49B | $6.48B | $6.22B | $5.75B | $5.76B |
| Intangible Assets | $9.18B | $9.69B | $8.36B | $1.85B | $2.22B |
| Total Assets | $29.44B | $28.05B | $26.84B | $24.55B | $23.88B |
| Liabilities | |||||
| Short-Term Debt | $0.08B | $1.75B | $0.15B | $0.00B | $1.00B |
| Accounts Payable | $0.43B | $0.42B | $0.40B | $0.49B | $0.59B |
| Total Current Liabilities | $3.35B | $5.53B | $3.43B | $3.27B | $4.30B |
| Long-Term Debt | $6.58B | $4.55B | $6.79B | $6.28B | $6.27B |
| Total Liabilities | $11.18B | $11.33B | $12.05B | $11.17B | $12.92B |
| Stockholders Equity | |||||
| Retained Earnings | $20.55B | $19.26B | $17.63B | $16.47B | $13.91B |
| Total Stockholders Equity | $18.26B | $16.72B | $14.80B | $13.40B | $10.90B |
| Total Liab & Equity(computed) | $29.44B | $28.05B | $26.84B | $24.56B | $23.81B |
| Debt Summary | |||||
| Total Debt | $6.95B | $6.63B | $7.34B | $6.61B | $7.60B |
| Net Debt | $3.94B | $4.26B | $6.29B | $3.19B | $5.34B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Biogen Inc.
关于Biogen Inc.（BIIB）资产负债表
Biogen Inc.总资产$29.44B，现金及短期投资$3.82B，总负债$11.18B，总债务$6.95B，股东权益$18.26B。
常见问题
BIIB · 4 问Biogen Inc.总债务$6.95B，净债务$3.94B。
BIIB total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10